Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12614000677606
ACTRN12614000677606
Not yet recruiting
未知

In patients with end stage renal failure on dialysis, does evening primrose oil, compared to omega -3 fish oil and placebo improve pruritis?

Department of Renal Medicine, WOLLONGONG hOSPITA0 sites90 target enrollmentJune 26, 2014
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsPruritis in End Stage Renal FailureFree Fatty Acid Intake and levels in End Stage Renal FailureRenal and Urogenital - Kidney diseaseMetabolic and Endocrine - Other metabolic disorders

Overview

Phase
未知
Intervention
Not specified
Conditions
Pruritis in End Stage Renal Failure
Sponsor
Department of Renal Medicine, WOLLONGONG hOSPITA
Enrollment
90
Status
Not yet recruiting
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 26, 2014
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Department of Renal Medicine, WOLLONGONG hOSPITA

Eligibility Criteria

Inclusion Criteria

  • •Patients on dialysis for 3 months or more

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Hemolysis of patients with end stage renal disease evaluated by erythrocyte creatineEnd stage renal disease
JPRN-UMIN000036418Kansai Medical University Medical Center69
Active, not recruiting
Not Applicable
A Study in Renal Predialysis and Dialysis Patients of the Safety, Tolerability, and Immunogenicity of Recombinant Hepatitis B Vaccine Manufactured With a Modified Process - NDProphylactic vaccination against infection with hepatitis B virus in renal predialysis and dialysis patientsMedDRA version: 9.1Level: LLTClassification code 10038474Term: Renal insufficiency
EUCTR2006-003650-20-ITMerck and Co Inc.276
Active, not recruiting
Phase 1
A Study in Renal Predialysis and Dialysis Patients of the Safety,Tolerability, and Immunogenicity of Recombinant Hepatitis BVaccine Manufactured with a Modified Process - Hepatitis B Vaccine (Recombinant) Dialysis StudyHepatitis BMedDRA version: 8.1Level: LLTClassification code 10019731Term: Hepatitis B
EUCTR2006-003650-20-GBMerck & Co Inc.,276
Not yet recruiting
Not Applicable
Blood-pressure variability and hypertensive control in patients with renal failure - the potential for smoother and superior control of mean blood-pressure and episodic hypertension through higher-dose dialysis.
ACTRN12614000929606Alfred Health Renal Unit60
Completed
Not Applicable
Intensive versus Conventional Renal Support in Acute Renal FailureAcute Renal FailureRenal and Urogenital - Kidney disease
ACTRN12610000044022S Department of Veterans Affairs Cooperative Studies Program1,164